Unlicensed stem cell doctor slapped with charges over patient's death

Charges of syndicated estafa, illegal medical practice and murder were filed on Tuesday against Dr. Zoharina Antonia Pedrera Carandang, also known as Dr. Antonia Carandang-Park, for practicing stem cell therapy on 23-year-old cancer patient Katherine Kate Tan. The treatment was alleged to have caused the Tan's death.

The charges were filed by Kate's father Bernard Tan before the Tagaytay Municipal Fiscal's Office. Aside from Carandang, owner and operator of Tagaytay-based Green & Young Health and Wellness Center, also charged were Joy Dimaranan, Estrella Maranan, Bebot Maranan and several other employees of the wellness center.

Tan also filed on Tuesday a separate administrative complaint against Park before Tagaytay's Office of the City Administrator, GMA News TV's Quick Response Team (QRT) reported.

According to the City Administrator's Office, Park had, in the past, applied for a permit to operate a medical clinic but was denied for failing to present the necessary documents, such as a Department of Health (DOH) certification.

Park, was, however, granted a permit to operate a massage clinic in 2012.

A caretaker at the wellness center, who received the copy of the criminal and administrative complaints, said Park had left the clinic Tuesday morning.

The Fiscal's Office also sent a letter to Park requiring her to respond to the complaint within two days, otherwise an investigation based only on the evidence presented by the Tans would be pursued.

The Office of the City Administrator also prohibited the wellness clinic from operating until a reply to the administrative complaint was filed.

Alternative treatment

In a separate complaint filed last month before the National Bureau of Investigation (NBI), Tan alleged that Park was not licensed by the Professional Regulation Commission (PRC) to practice medicine in the Philippines.

Read more:
Unlicensed stem cell doctor slapped with charges over patient's death

Stem Cell Basics: Introduction [Stem Cell Information]

Introduction: What are stem cells, and why are they important? What are the unique properties of all stem cells? What are embryonic stem cells? What are adult stem cells? What are the similarities and differences between embryonic and adult stem cells? What are induced pluripotent stem cells? What are the potential uses of human stem cells and the obstacles that must be overcome before these potential uses will be realized? Where can I get more information?

Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive. When a stem cell divides, each new cell has the potential either to remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell.

Stem cells are distinguished from other cell types by two important characteristics. First, they are unspecialized cells capable of renewing themselves through cell division, sometimes after long periods of inactivity. Second, under certain physiologic or experimental conditions, they can be induced to become tissue- or organ-specific cells with special functions. In some organs, such as the gut and bone marrow, stem cells regularly divide to repair and replace worn out or damaged tissues. In other organs, however, such as the pancreas and the heart, stem cells only divide under special conditions.

Until recently, scientists primarily worked with two kinds of stem cells from animals and humans: embryonic stem cells and non-embryonic "somatic" or "adult" stem cells. The functions and characteristics of these cells will be explained in this document. Scientists discovered ways to derive embryonic stem cells from early mouse embryos nearly 30 years ago, in 1981. The detailed study of the biology of mouse stem cells led to the discovery, in 1998, of a method to derive stem cells from human embryos and grow the cells in the laboratory. These cells are called human embryonic stem cells. The embryos used in these studies were created for reproductive purposes through in vitro fertilization procedures. When they were no longer needed for that purpose, they were donated for research with the informed consent of the donor. In 2006, researchers made another breakthrough by identifying conditions that would allow some specialized adult cells to be "reprogrammed" genetically to assume a stem cell-like state. This new type of stem cell, called induced pluripotent stem cells (iPSCs), will be discussed in a later section of this document.

Stem cells are important for living organisms for many reasons. In the 3- to 5-day-old embryo, called a blastocyst, the inner cells give rise to the entire body of the organism, including all of the many specialized cell types and organs such as the heart, lung, skin, sperm, eggs and other tissues. In some adult tissues, such as bone marrow, muscle, and brain, discrete populations of adult stem cells generate replacements for cells that are lost through normal wear and tear, injury, or disease.

Given their unique regenerative abilities, stem cells offer new potentials for treating diseases such as diabetes, and heart disease. However, much work remains to be done in the laboratory and the clinic to understand how to use these cells for cell-based therapies to treat disease, which is also referred to as regenerative or reparative medicine.

Laboratory studies of stem cells enable scientists to learn about the cells essential properties and what makes them different from specialized cell types. Scientists are already using stem cells in the laboratory to screen new drugs and to develop model systems to study normal growth and identify the causes of birth defects.

Research on stem cells continues to advance knowledge about how an organism develops from a single cell and how healthy cells replace damaged cells in adult organisms. Stem cell research is one of the most fascinating areas of contemporary biology, but, as with many expanding fields of scientific inquiry, research on stem cells raises scientific questions as rapidly as it generates new discoveries.

I.Introduction|Next

Go here to see the original:
Stem Cell Basics: Introduction [Stem Cell Information]

Doctors perform living donor stem cell transplants in eye …

by Jim Ritter

Debra Astrug, who once feared she was going blind, can see fine now, thanks to a stem cell transplant she received from her daughter, Jessica.

The stem cells came from two pieces of tissue that Dr. Charles Bouchard of Loyola University Medical Center removed from the cornea of Jessica's left eye. When Bouchard proposed the innovative procedure, she immediately agreed.

"It's my mom," Jessica said. "If she needs part of my eye, she's got it."

Before the transplant, Debra Astrug's vision was extremely blurred like looking through a glass smeared with Vaseline. She could not read or drive. And when Jessica took her to buy groceries, Debra had to bring a magnifying glass to read labels.

"It was horrible," she said.

But since receiving the stem cell transplant, and wearing special contact lenses, Debra Astrug's vision has improved to 20/25.

Loyola is among a handful of centers that perform living-related corneal stem cell transplants on patients who have too few corneal stem cells. Ophthalmologists traditionally have treated such deficiencies by transplanting stem cells from deceased donors. In these cases, in order to prevent the patient's immune system from rejecting the donated stem cells, patients take immune-suppressing drugs for several years or longer. But such drugs can have toxic side effects and also increase the risk of infections, said Bouchard, who is chair of Loyola's Department of Ophthalmology.

Bouchard is performing corneal/limbal stem cell transplants from living donors who are first-degree relatives of patients. Because the donor and recipient are closely related, most patients can avoid taking systemic immune-suppressing drugs.

Stem cell transplants are the treatment of choice for patients who have severe cases of limbal stem cell deficiency, or LSCD. (Limbal refers to the border of the cornea and sclera. The cornea is the transparent front part of the eye, and the sclera is the white part of the eye.)

Read more:
Doctors perform living donor stem cell transplants in eye ...

Beverly Hills Orthopedic Institute Now Offering Stem Cell Procedures for Hip Arthritis to Help Patients Avoid Surgery

Beverly Hills, California (PRWEB) May 05, 2014

The top stem cell orthopedic doctor in Beverly Hills at Beverly Hills Orthopedic Institute is now offering stem cell procedures for hip arthritis to help patients avoid the need for joint replacement. The procedures are administered by a highly respected, Double Board Certified Beverly Hills orthopedic doctor, Dr. Raj. Call (310) 438-5343 for more information and scheduling.

Millions of Americans suffer from debilitating hip arthritis and hundreds of thousands annually undergo hip replacement procedures. While hip replacement typically provides exceptional pain relief, it is a major procedure with potential complications in the short or long term. Therefore, it is recommended to only have the procedure as a last resort.

Stem cell procedures for hip arthritis offer the potential for not only relieving pain, but also regenerating damaged tissue. Dr. Raj offers multiple types of stem cell procedures.

The first type of procedure involves bone marrow from the patient. The marrow is harvested with a short outpatient procedure, with the marrow being immediately processed to concentrate the stem cells and growth factors. At the same setting, the concentrate is then injected into the painful hip. Both can be treated at the same time.

The second type of procedure involves amniotic derived stem cells, which are harvested from consenting donors after a scheduled c-section. No fetal tissue is involved, alleviating any ethical concerns. The fluid is processed at an FDA regulated lab and is extremely rich with stem cells, growth factors, anti-inflammatory material and more.

Results in small studies looking at regenerative medicine injections with stem cells have shown excellent pain relief for joint arthritis, tendonitis and ligament injury. Patients are often able to avoid the need for surgery and get back to participating in desired recreational activities.

Dr. Raj has been named one of the top orthopedic doctors in Los Angeles on several occasions, and is also a medical correspondent for ABC News. He is an expert in the nonoperative and operative treatment of hip arthritis.

For those desiring top notch regenerative medicine treatment options for hip arthritis in Los Angeles and Beverly Hills, call (310) 438-5343.

Read the original post:
Beverly Hills Orthopedic Institute Now Offering Stem Cell Procedures for Hip Arthritis to Help Patients Avoid Surgery

FDAs Adult Stem Cell Research

Scientists who are part of the Food and Drug Administrations MSC Consortium, are studying adult mesenchymal stem cells (MSCs) that could eventually be used to repair, replace, restore or regenerate cells in the body, including those needed for heart and bone repair.

According to the FDA, theinvestigational work is unprecedented: Seven labs at FDA's Center for Biologics Evaluation and Research formed the consortium to fill in gaps in knowledge about how stem cells function.

A consumer update from FDA quotes Carolyn A. Wilson, Ph.D., associate director for research at the center, as saying, This research aims to facilitate development of this important class of innovative medical products. Its the first time weve done anything like this, and its proven to be a very useful approach. Its worked so well because this is a huge, complicated project that requires expertise in many different technologies and methods.

The research could ultimately be key to the advancement of personalized medicine, the practice in which medical treatment is tailored to the needs of an individual patient.Its not science fiction,says Steven R. Bauer, Ph.D., chief of the Cellular and Tissue Therapy Branch in FDAs Office of Cellular Tissue and Gene Therapies.For me, regenerative medicine is the most exciting part of what we regulate in our office.

Visit FDAs Consumer Updates page for more information on adult sem cells and regenerative medicine.

Read the original:
FDAs Adult Stem Cell Research

Health Beat: Growing stem cells in space: Medicine's next big thing?

JACKSONVILLE, Fla. -

Hemorrhagic stroke is responsible for more than 30 percent of all stroke deaths. It happens when a weakened blood vessel ruptures and bleeds into the brain.

Its something Jon Galvan experienced five years ago when he almost died from a hemorrhagic stroke while at work.

"I was typing away and I felt a pop in my head," Galvan said.

He was able to recover, but Dr. Abba Zubair, medical director of transfusion medicine and stem cell therapy at Mayo Clinic, Florida, said not everyone is as fortunate.

"If it happens, you either recover completely or die," Zubair said. "Thats what killed my mother."

Zubair said he wants to send bone marrow derived stem cells to the international space station.

"Based on our experience with bone marrow transplant, you need about 200 to 500 million cells," Zubair said.

But conventionally grown stem cells take a month. Experiments on earth have shown that stem cells will grow faster in less gravity.

"Five to ten times faster, but it could be more," Zubair said.

Continued here:
Health Beat: Growing stem cells in space: Medicine's next big thing?

The New Cellular Medicine from MetroMD Stem Cell PRP Helps Tennis Elbow Sufferers, and Other Athletes to Recover …

Los Angeles, CA (PRWEB) May 05, 2014

Tennis elbow is a common condition affecting 40-60 years aged adults. Though it is not a critical condition, it is potentially disabling in the sense that it restricts the certain activities of tennis players. MetroMD Institute of Regenerative Medicine, Los Angeles, offers an innovative treatment with PRP- Platelet Rich Plasma- a minimally invasive procedure. The therapy takes fewer months for rehabilitation and correct elbow injury in a way that traditional methods cannot do. Source: Dr. Alex Martin - MetroMD Institute of Regenerative Medicine, 7080 Hollywood Blvd, Los Angeles, California.

Tennis elbow is caused by repetitive strain to the tendon in the elbow. Consequently, due to the overuse and strain, elbows have damaged ligaments in the area. Scientifically, this condition is known as lateral epicondylitis. MetroMD, LA, treats vastitude of players with tennis elbow with a minimally invasive procedure with less time for rehabilitation. Dr. Alex Martin, Medical Doctor at the Institute, introduces the latest technologies in regenerative medicine - prolotherapy and platelet-rich plasma treatment (PRP) is one of them. The therapy involves the use of stem cells harvested from the patients bone marrow along with PRP and re-injecting the derived concentrated solution to the damaged soft tissue in the elbow for regeneration. Further, the stem cell specialist accurately places the cells to the troubled area. Once the cells are placed as the way they are required to, the healing process commences. Gradually, the sport players start to restore to full recovery. Patients become able to reuse their elbow and come back to normalcy to continue the sports for as long as they want.

The revolutionary stem cell option is a new attempt to cure the tennis elbow in players with PRP injections to better health. The best part of the treatment is it restores to full health without having the need to go for invasive procedure, unlike conventional surgical methods." says Alex Martin, Medical Doctor, MetroMD, Los Angeles. To know more about the regenerative medicine, please visit http://www.metromd.net.

About MetroMD

MetroMD is a Los Angeles based clinical institute and a leading provider of PRP, Stem Cell Therapy and numerous others. The institute treats the patients with latest technology to treat aging, improve sports performance, texture of hair, nail with HGH therapy. All the treatments are FDA approved and hence considered safe. The institute runs licensed Stem Cell Therapy clinic in Los Angeles. __title__ How to Repair Elbow Joints with PRP]

Read more:
The New Cellular Medicine from MetroMD Stem Cell PRP Helps Tennis Elbow Sufferers, and Other Athletes to Recover ...

Irvine Stem Cell Treatment Center Upcoming Lecture Tour

Irvine, California (PRWEB) May 05, 2014

The Irvine Stem Cell Treatment Center, PC, located in Irvine, California, announces a series of free public seminars on the use of stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief.

The tour dates and locations are as follows:

Wednesday, May 7, 2014 @ 3pm Coco's Restaurant 18380 Brookhurst St., Fountain Valley, CA 92708

Thursday, May 8, 2014 @ 3pm Polly's Pies 18132 Imperial Hwy., Yorba Linda, CA 92886

Friday, May 9, 2014 @ 2pm Polly's Pies 23701 Moulton Pkwy., Laguna Woods, CA 92637

At the Irvine Stem Cell Treatment Center, utilizing investigational protocols, adult adipose derived stem cells (ADSCs) can be deployed to improve patients quality of life with a number of degenerative conditions and diseases. ADSCs are taken from the patients own adipose (fat) tissue (also called stromal vascular fraction (SVF). Adipose tissue is exceptionally abundant in ADSCs. The adipose tissue is obtained from the patient during a 15 minute mini-liposuction performed under local anesthesia in the doctors office. SVF is a protein-rich solution containing mononuclear cell lines (predominantly autologous mesenchymal stem cells), macrophage cells, endothelial cells, red blood cells, and important Growth Factors that facilitate the stem cell process and promote their activity.

ADSCs are the body's natural healing cells - they are recruited by chemical signals emitted by damaged tissues to repair and regenerate the bodys damaged cells. The Irvine Stem Cell Treatment Center only uses autologous stem cells from a person's own fat no embryonic stem cells are used. Our current areas of study include: Heart Failure, Emphysema, COPD, Asthma, Parkinsons Disease, Stroke, Multiple Sclerosis, and orthopedic joint injections. For more information, or if someone thinks they may be a candidate for one of the stem cell protocols offered by Irvine Stem Cell Treatment Center, they may contact Dr. Gionis directly at (949) 679-3889, or see a complete list of the Centers study areas at http://www.StemCellsUSA.net.

About Irvine Stem Cell Treatment Center: The Irvine Stem Cell Treatment Center is an affiliate of the Cell Surgical Network (CSN). We provide care for people suffering from diseases that may be alleviated by access to adult stem cell based regenerative treatment. We utilize a fat transfer surgical technology to isolate and implant the patients own stem cells from a small quantity of fat harvested by a mini-liposuction on the same day. The investigational protocols utilized by the Irvine Stem Cell Treatment Center have been reviewed and approved by an IRB (Institutional Review Board) which is registered with the U.S. Department of Research Health, Office of Human Reseach Protections (OHRP); and the study is registered with Clinicaltrials.gov, a service of the U.S. National Institutes of Health (NIH). For more information contact: Info(at)StemCellsUSA(dot)net or visit our website: http://www.StemCellsUSA.net.

Excerpt from:
Irvine Stem Cell Treatment Center Upcoming Lecture Tour

Scoop.it

IBOtoolbox Press Release: The Power of our God Given Adult Stem Cells and how Stem Cell Nutrition capsules mobilize millions more bone marrow adult stem cells into blood circulation within minutes of consumption..and helped restore my eyesight.

EJ Morris's insight:

When Laurence Chilcott talks ... I Listen ! Especially when the topic is natural wellness, optimal health, and anti-aging.

Delete the scoop?

Are you sure you want to delete this scoop?

Yes No

Go see the record breaking numbers.. the stem cell niche markets are exploding, and Stemtech is the global leader in creating and marketing the World's First patented Stem Cell Nutrition Supplements for people and animals.

EJ Morris's insight:

EJ Morris markets stem cell nutrition products and has been a STEMTech Independent Business Partner since 2005.

Witness the global growth of Stem Cell Nutrition into Russia and virtual stem cell nutrition distributors in India here... http://www.adult-stemcells-blog.com/stem-cell-markets.html

Go here to read the rest:
Scoop.it

Listing of Comments on Draft NIH Human Stem Cell Guidelines

On April 23, 2009, the National Institutes of Health (NIH) published draft stem cell guidelines for public comment in the Federal Register. The purpose of these guidelines are to implement President Barack Obamas Executive Order 13505 Removing Barriers to Responsible Scientific Research Involving Human Stem Cells, which was issued on March 9, 2009.

NIH received 49,015 comments by May 26, 2009, the closing date of the comment period, and have compiled these comments on this website. Any comments received via email or mail after the May 26 deadline are not included on this website. In reviewing the comments, NIH determined that 60 comments were inappropriate (i.e., contained SPAM responses or offensive language), and these comments have been excluded from this website. In addition, to protect the identities and personal information of individuals who submitted comments, NIH has removed personally identifiable information from the comments on this website even though individuals consented that the information provided could be made available for public review and posting.

| Records 46624 - 46723 of 49015 |

Significant strides have been made over the past decade, and the final guidelines issued by NIH must build on this progress so that cures and new therapies can get to patients as quickly as possible. The final guidelines should not create new bureaucratic hurdles that will slow the pace of progress.

No matter how you look at an embryo, it is A HUMAN BEING, and by "using" it to attempt to save another, you are still taking a human life. Taking one life to save another, MAYBE, that is not even been proven, murder is taking place. No one can decide to end a life without paying a price. If the baby was born live, and then "killed", you would put that person up for being charged for murder. Because it is in the safe haven of the mother's womb doesn't take away from the FACT that is is a human being. JUST LIKE YOU.

Please listen to the pleas of many voters who acknowledge that life begins at conception. Also, that our Creator placed that special life for a special purpose. Being martyred is NOT one of those chosen reasons. God will accept that baby into Heaven and you will have to account for taking an innocent life.

Look deep into your conscience and also read the Constitution of the United States. It gives rights to the unborn. Dare you cross those lines and you will have retribution from above.

What would our founding fathers say? They founded our country on Christian Values. Value your conscience. Thank you for reading this email.

We currently use the NIH approved lines WA09, WA01, HES-3, HES-2 in our research developing stem cell therapies for lung disorder such as Cystic Fibrosis.

[2] Most existing U.S. lines have been derived in accordance with the core principles in the ISSCRs guidelines and consistent with the established federal regulatory framework involving IRB oversight and approval. In some instances, additional specialized embryonic stem cell research oversight committees (ESCROs), and other oversight methods in other countries (referred to as SCROs in ISSCR Guidelines), have also provided oversight. Established policy has demonstrated that this self-regulatory structure has provided a sound ethical foundation for stem cell research. In developing the final Guidelines the NIH should consider this well-established framework of independent oversight and give weight to its determinations.

See original here:
Listing of Comments on Draft NIH Human Stem Cell Guidelines